Clients Hail Standard Chartered's Market Outlook for 2025 as Best-in-Class Wealth and Investment ...
Standard Chartered Bank's recent Market Outlook event has received resounding praise from clients, with many hailing it as the ...
Dignify Therapeutics, a biotechnology company dedicated to restoring voluntary bowel and bladder function in patients with ...
Highlights,Several major investment firms have adjusted their stakes in Axsome Therapeutics, reflecting evolving market ...
Highlights,Mineralys Therapeutics' stock opened at $10.15, reflecting recent market adjustments.,Executive transactions ...
Patients Achieved Remission Within 30 Days in Cohort 1 of the Mipletamig RAINIER Dose Optimization Trial for Frontline AML Patients, Trial Enrollment Continues Promising Data, including a 59% Stable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback